Page 13 - 北京京煤集团总医院第十一届·2023学术年会论文集
P. 13

北京京煤集团总医院                                                          第十一届·2023 学术年会论文集

                       We found that differentially expressed CRs are mainly involved in cell cycle pathways. Severe
                   asthma is characterized by proliferation of airway smooth muscle (ASM)  [39] . Stimulation, including

                   growth  factors  and  extracellular  proteins,  regulates  mitosis,  which  in  turn  induces  ASM  cell
                   proliferation   [40].   The  patients  included  in  this  study  were  partially  treated  with  ICS  or  oral
                   corticosteroids (OCS) in a previous study  [17] . The anti-asthmatic approach described above is an
                   effective inhibitor of ASM cell proliferation. Corticosteroids inhibit the signaling pathways of cell

                   cycle progression  [41] . Differentially expressed CRs have also been found to be involved in lysine
                   degradation.  Lysine  residues  can  increase  pro-inflammatory  factor  activity  and  affect  collagen
                   synthesis. Thus,  lysine  degradation  can  modulate  airway  inflammation  and  airway  remodeling,
                   which are key pathogenic features of asthma  [26] . Drugs that target lysine may be important in the

                   treatment of severe asthma.
                       CRs control chromatin structure and function by catalyzing and binding histone modifications
                   and  are  regulators  of  epigenetics   [42] .  Asthma  patients  were  found  to  have  enhanced  histone
                   acetyltransferases activity and reduced histone deacetylases activity. These modifications may lead

                   to increased expression of genes associated with the inflammatory response profile of asthma  [43] .
                   Another study related to differentially expressed chromatin-modifying enzymes found that cigarette
                   smoke  differentially  affected  the  expression  of  epigenetic  regulators  in  patients  with  chronic

                   obstructive pulmonary disease, further regulating the expression of target genes  [44] . This study is
                   the first to investigate the role of differentially expressed CRs in severe asthma, which may provide
                   new targets for the treatment of asthma in the future.
                       This study had some limitations. First, the sample size may not be sufficiently representative.

                   Second, the results were not experimentally validated. Moreover, multiple prospective studies are
                   still needed.
                       In  conclusion,  this  study  constructed  a  risk  model  with  good  predictive  performance  by
                   screening  for  differentially  expressed  CRs  between  subjects  with  severe  asthma  and  healthy

                   individuals and by selecting hub CRs among them. The results of this study provide new insights
                   into the mechanisms underlying CRs in severe asthma.
                   Declarations:

                   Ethics approval and consent to participate:

                   GEO belong to public databases. The patients involved in the database have obtained ethical
                   approval. Users can download relevant data for free for research and publish relevant articles. Our
                   study is based on open source data, so there are no ethical issues and other conflicts of interest.
                   Consent for publication:

                   Not applicable.
                   Availability of data and materials:

                   The datasets GSE143303 for this study can be found in the GEO database Home-GEO-NCBI
                   (https://www.ncbi.nlm.nih.gov/geo/) .Data openly available in a public repository.
                   Competing of interest:


                                                           - 9 -
   8   9   10   11   12   13   14   15   16   17   18